32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Despite the great strides that have been made in research for Lou Gehrig s Disease in the twentieth century, effective treatments are sorely lacking. This is a devastating neurodegenerative disorder that progresses rapidly to paralysis and death. What will we do to address treatment options? Waging a War against Motor Neuron Disease describes the development of a cell model and biochemical assays that may lead to the discovery of mechanisms of ALS. This original work provides groundbreaking evidence that proteomics analysis in spinal cord extracts of ALS mice may yield new protein targets and…mehr

Produktbeschreibung
Despite the great strides that have been made in
research for Lou Gehrig s Disease in the twentieth
century, effective treatments are sorely lacking.
This is a devastating neurodegenerative disorder
that progresses rapidly to paralysis and death.
What will we do to address treatment options?
Waging a War against Motor Neuron Disease describes
the development of a cell model and biochemical
assays that may lead to the discovery of mechanisms
of ALS. This original work provides groundbreaking
evidence that proteomics analysis in spinal cord
extracts of ALS mice may yield new protein targets
and suggests that therapeutic approaches can be
derived from developments in the laboratory. This
book describes translational research that is
leading to promising findings at the J Thomas May
Center for Amyotrophic Lateral Sclerosis (ALS). The
May Center is focused on moving new treatments
rapidly from the laboratory to the clinic.
Autorenporträt
Page Jones, PhD: Studied Environmental Health Sciences at the
University of Alabama at Birmingham.

John P.Crow, PhD: Professor and Director, University of Arkansas
for Medical Sciences, J Thomas May Center for Amyotrophic
Lateral Sclerosis